Home › Kanser ng Endometrium › Connecticut › New Haven
Pag-aaral pangklinika para sa Kanser ng Endometrium sa New Haven, CT
14 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng New Haven (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Yale Cancer Center, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- Yale Cancer Center, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- Yale University, Yale Cancer Center, New Haven
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Nagre-recruitPhase 3
- Yale University School of Medicine, New Haven
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Nagre-recruitPhase 3
- Yale University School of Medicine ( Site 6009), New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
- Normunity Investigational Site, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Yale University School of Medicine, New Haven
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Nagre-recruitPhase 2
- Smilow Cancer Hospital at Yale New Haven, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Yale University, Yale Cancer Center, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Yale University, Yale Cancer Center, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Nagre-recruitPhase 1/2
- Yale Cancer Center, New Haven
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Nagre-recruitPhase 1/2
- Yale University, New Haven
Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod
- Houston, TX68 pag-aaral
- New York City, NY52 pag-aaral
- Boston, MA50 pag-aaral
- Arlington, VA39 pag-aaral
- Nashville, TN38 pag-aaral
- Los Angeles, CA34 pag-aaral
- St. Louis, MO29 pag-aaral
- Philadelphia, PA28 pag-aaral
- San Antonio, TX27 pag-aaral
- Columbus, OH25 pag-aaral
- Oklahoma City, OK25 pag-aaral
- Chicago, IL25 pag-aaral
Iba pang pag-aaral sa New Haven
- Non-Small Cell Lung Cancer41 pag-aaral
- Kanser sa Suso38 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Metastatic Cancer23 pag-aaral
- Kanser sa Baga22 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg22 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Colorectal Cancer20 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Alcohol Use Disorder (AUD)17 pag-aaral
- Overdose ng Opioid17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.